Breaking News

Thermo Fisher Scientific Introduces Gibco CTS DynaXS Single Use Bioreactor

Offers a scalable platform from small process development batches to larger cGMP manufacturing runs.

Author Image

By: Charlie Sternberg

Associate Editor

The CTS DynaXS Single Use Bioreactor.

Thermo Fisher Scientific Inc. has introduced the Gibco CTS DynaXS Single Use Bioreactor, a purpose-built expansion platform designed to help cell therapy developers scale manufacturing with precise control, flexibility, and regulatory readiness. “Cell therapy manufacturers are navigating a rapidly expanding pipeline and increasing regulatory expectations,” said Sara Henneman, vice president and general manager of Thermo Fisher Scientific’s cell culture and cell therapy business. “The CTS Dyna...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters